Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

Pharmaceutical

Idorsia

Jean-Paul Clozel

Fenna. Gloggner

Peter Rooney

Scotty Bowman

Georg Rüedi

Thomas Weller

Eva Caroff

Christophe Segalini

Antonio Olivieri

Julien Gander

Alberto Gimona

Alexander Khatuntsev

Martine Clozel

Olivier Lambert

André C. Muller

Andrew C. Weiss

Guy Braunstein

Markus A. Riederer

The executive team at Idorsia has a long history of experience in the pharmaceutical industry. SVP, Head of Global Human Resources, Invited Faculty Lecturer at Academia Engiadina Samedan, and Certified Professional Coach at Independent are just a few of the team's many accomplishments. The team is also well-educated, with degrees in Chemistry, Medical Biochemistry with Physiology, and Safety Pharmacology-Pre Clinical Drug Expertise.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Idorsia

Leadership Team

Board of Directors